Comparing strategies to guide blood pressure treatment

April 18, 2018 by Anna Williams, Northwestern University
Credit: CC0 Public Domain

A strategy that examines a patient's overall heart disease and stroke risk to determine blood pressure treatment—rather than blood pressure levels alone—is more effective at preventing events like heart attacks, strokes and death, according to a new study published in PLOS Medicine.

"These results challenge past paradigms in hypertension management and highlight the merits of using predicted cardiovascular risk to guide blood pressure-lowering intensity," said first author Kunal Karmali, '07 MD, MS, '16 GME, a Northwestern Medicine cardiologist and a former fellow in Preventive Medicine.

Donald Lloyd-Jones, MD, ScM, senior associate dean for Clinical and Translational Research and chair of Preventive Medicine, was also a co-author of the paper.

Traditionally, clinical guidelines on the use of blood pressure-lowering drugs have been based primarily on a patient's blood pressure levels. In contrast, guidelines for aspirin and cholesterol management use a multivariable cardiovascular disease (CVD) risk assessment approach. Such an assessment takes into account a range of factors, such as age, sex, total cholesterol, high density lipoprotein cholesterol, systolic blood pressure and smoking status to guide treatment initiation and intensity.

"We can't focus only on the blood pressure number—we have to think about the whole patient and the context of their other risk factors."

Previous research—including a study published in The Lancet co-authored by Karmali and Lloyd-Jones—has also suggested the benefit of using CVD risk assessment in making blood pressure treatment decisions. But until now, no study has directly compared the two strategies using clinical trial data of actual patient outcomes.

In the current study, the international team of investigators analyzed individual data of more than 48,000 participants in 11 clinical trials. They compared the two strategies across the spectrum of risk and , and demonstrated that a treatment strategy based on predicted five-year CVD risk could prevent more events —including stroke, coronary heart disease, heart failure and CVD death—as well as require the treatment of fewer people, than a strategy based on level alone.

Although future prospective studies are needed to confirm the results of the study, the authors note that the findings lend further support to the role of CVD risk assessment in blood pressure treatment decisions for moderate- to high-risk patients, especially those without diabetes or existing cardiovascular disease.

"These data strongly support the paradigm shift in how we think about preventing cardiovascular events with blood pressure lowering. We can't focus only on the blood pressure number—we have to think about the whole patient and the context of their other risk factors," Lloyd-Jones said. "The recent 2017 guidelines from the American Heart Association and American College of Cardiology specifically recommend assessing risk quantitatively, and considering that in addition to the level."

Explore further: No cardiovascular disease reduction with intensive blood pressure lowering treatment

More information: Kunal N. Karmali et al. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data, PLOS Medicine (2018). DOI: 10.1371/journal.pmed.1002538

Related Stories

No cardiovascular disease reduction with intensive blood pressure lowering treatment

November 13, 2017
Blood pressure lowering treatment does not reduce death or cardiovascular disease in healthy individuals with a systolic blood pressure below 140. This is shown in a systematic review and meta-analysis from Umeå University. ...

Intensive BP goals reduce risk of cardiovascular events

December 19, 2017
(HealthDay)—Intensive blood pressure lowering may similarly decrease cardiovascular events in both patients with and patients without type 2 diabetes mellitus, according to a study published online Dec. 6 in Diabetes Care.

Combining drugs that lower blood pressure and cholesterol could do more to prevent stroke

January 25, 2018
Combining medication that lowers blood pressure with medication that lowers cholesterol reduced first-time strokes by 44 percent, according to research presented at the American Stroke Association's International Stroke Conference ...

Back to basics for heart health

February 2, 2018
As heart month kicks off, doctors at Baylor College of Medicine say the first step to taking control of your health and preventing cardiovascular disease is understanding the basics and what they represent for your heart.

Blood pressure medication can't undo all damage

October 21, 2015
Treating out-of-control blood pressure with antihypertensive medication can greatly reduce your risk for heart attack, stroke and heart failure, but the current approach to treatment can't undo all of the previous damage ...

Intensive blood pressure lowering benefits patients with chronic kidney disease

June 23, 2017
Results from a recent clinical trial indicate that intensive blood pressure lowering reduces chronic kidney disease (CKD) patients' risks of dying prematurely or developing cardiovascular disease. The findings appear in an ...

Recommended for you

Genomic autopsy can help solve unexplained cardiac death

August 15, 2018
Molecular autopsies can reveal genetic risk factors in young people who unexpectedly die, but proper interpretation of the results can be challenging, according to a recent study published in Circulation.

Neonatal pig hearts can heal from heart attack

August 15, 2018
While pigs still cannot fly, researchers have discovered that the hearts of newborn piglets do have one remarkable ability. They can almost completely heal themselves after experimental heart attacks.

Fifty percent of cardiovascular patients suffer from multiple diseases

August 15, 2018
New research led by The University of Western Australia has revealed that one in two patients admitted to hospital with a cardiovascular disease is suffering from multiple chronic medical conditions which required complex ...

Innovative triple pill significantly lowers blood pressure, study finds

August 14, 2018
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.

Drug repurposing study sheds light on heart disease risk

August 14, 2018
A team led by researchers at Brigham and Women's Hospital has developed a computational technique to reveal the unknown side effects—both good and bad—of hundreds of drugs. That knowledge could help pharmacologists discover ...

Rethinking the stroke rule 'time is brain'

August 13, 2018
In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.